Wall Street got a fresh mega-deal Monday that has nothing to do with chips or chatbots: Michael Dell's family investment office is buying an insurance company.

The Baldwin Group (NASDAQ: BWIN), a Tampa-based insurance distribution and risk-management firm, announced a definitive agreement to go private through a majority investment led by Sequence Holdings and DFO Management, the Dell family's investment vehicle, in an all-cash deal valuing the company at roughly $7.7 billion.

Shareholders will collect $32.50 for every share they hold — an equity purchase price near $4.6 billion once Baldwin's roughly $3.1 billion in net debt is folded in, or about 20 times the company's trailing annual adjusted EBITDA of $396 million. The stock, which had already run up on deal chatter, was trading around $32.40 Tuesday morning, just under the buyout price and up roughly 1% on the day — a sign investors expect the deal to close as written. According to the companies, the offer represents an 88% premium over Baldwin's unaffected closing price back on June 17, before takeover speculation began pushing the stock higher.

Why an insurance brokerage?

Baldwin serves more than 3 million clients across commercial insurance, employee benefits and reinsurance brokerage. Sequence, a New York holding company that buys "service-economy" businesses and rebuilds them on its own tech stack, is positioning the deal as a bet that AI-driven automation can wring new efficiency out of an industry still leaning heavily on paperwork and phone calls.

"THIS PARTNERSHIP WILL GIVE BALDWIN THE LONG-DURATION CAPITAL AND FRONTIER AI EXECUTION TO INVEST AND MOVE AT THE PACE THIS MOMENT DEMANDS." — Baldwin CEO Trevor Baldwin

Michael Dell, whose fortune was built rebuilding a hardware company into a private-equity-backed powerhouse before taking it public again, framed the target similarly, saying Baldwin has built "a genuine data and platform advantage" over 15 years. Sequence CEO Michael J. Lee said the firm intends to pair its engineering talent with "patient capital" to transform how the brokerage operates. Eligible Baldwin employees will be allowed to roll part of their equity into the newly private company rather than cash out entirely, and the transaction carries no financing condition — a detail dealmakers typically read as a sign the buyers are confident the money is already lined up.

The deal, which Baldwin's board approved unanimously after a review by a special committee, was run through a heavyweight roster of advisers including Ardea Partners, Piper Sandler, Morgan Stanley, Barclays and Wells Fargo, with Davis Polk & Wardwell and Latham & Watkins handling the legal work — a lineup befitting one of the larger insurance-sector take-privates in recent memory.

The transaction still needs sign-off from Baldwin shareholders and regulators and is expected to close in the first quarter of 2027, after which BWIN will be delisted from the Nasdaq. Until then, Baldwin continues trading and operating as a public company, and analysts will be watching for any rival bidders — though with the stock already pinned near the offer price, Wall Street is betting this one is close to done.